Daniel Golden

Daniel Golden is a seasoned executive in the biopharmaceutical sector, currently serving as Vice President of Global Research, Discovery & Breakthrough Innovation at Elanco since December 2015. Golden's extensive experience encompasses roles such as Executive Director of Next Generation Product Development, where innovative product and service development initiatives were fostered, and Senior Director positions overseeing commercial and product development within the pet specialty and animal care sectors. Earlier career stages include directing pharmaceutical R&D projects at Merial, providing technical consultancy in patent litigation, and engaging in significant academic and research roles at institutions such as Northwestern University and the Marine Biological Laboratory. Golden holds a Ph.D. in Biochemistry & Molecular Genetics from the University of Alabama at Birmingham and a B.S. in Microbiology from Auburn University. Additionally, Golden contributes to the industry through board memberships at BioCrossroads and the Indiana Biosciences Research Institute.